175 related articles for article (PubMed ID: 26625229)
21. Exocrine Pancreatic carcinoma in Tunisia: A retrospective study about 158 cases.
El Guesmi S; Ben Nasr S; Afrit M; Labidi S; Boussen H
Tunis Med; 2015 Feb; 93(2):73-5. PubMed ID: 26337302
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in ductal pancreatic cancer.
Yeo CJ; Cameron JL
Langenbecks Arch Surg; 1998 Apr; 383(2):129-33. PubMed ID: 9641885
[TBL] [Abstract][Full Text] [Related]
23. Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
Moghanaki D; Mick R; Furth EE; Sohal D; Salmon PM; Behbahani A; Morgans AK; Miller SM; Giantonio BJ; Whittington RW; Haller DG; Rosato EF; Plastaras JP
JOP; 2011 Sep; 12(5):438-44. PubMed ID: 21904068
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of pancreatic adenocarcinoma].
Delpero JR; Giovannini M
Rev Prat; 2002 Sep; 52(14):1534-9. PubMed ID: 12412300
[TBL] [Abstract][Full Text] [Related]
25. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
Tempero MA; Behrman S; Ben-Josef E; Benson AB; Cameron JL; Casper ES; Hoffman JP; Karl RC; Kim P; Koh WJ; Kuvshinoff BW; Melvin WS; Muscarella P; Sasson AR; Shibata S; Shrieve DC; Talamonti MS; Tyler DS; Vickers SM; Warren RS; Willett C; Wolff RA;
J Natl Compr Canc Netw; 2005 Sep; 3(5):598-626. PubMed ID: 16194453
[No Abstract] [Full Text] [Related]
27. Treatment of resectable and locally advanced pancreatic cancer.
Kuvshinoff BW; Bryer MP
Cancer Control; 2000; 7(5):428-36. PubMed ID: 11000612
[TBL] [Abstract][Full Text] [Related]
28. [Trend in the management of pancreatic adenocarcinoma--Japan vs. US and Europe].
Wada K; Takada T; Amano H; Yoshida M; Miura F; Toyota N; Kato K; Isaka T; Nagashima I
Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):187-91. PubMed ID: 16878412
[TBL] [Abstract][Full Text] [Related]
29. Treatment of pancreatic adenocarcinoma: a European perspective.
Gouma DJ; Busch OR; van Gulik TM
Surg Oncol Clin N Am; 2008 Jul; 17(3):569-86, ix. PubMed ID: 18486884
[TBL] [Abstract][Full Text] [Related]
30. [Current diagnosis and treatment of pancreatic cancer].
Heinrich S; Schäfer M; Bauerfeind P; Pestalozzi BC; Clavien PA
Praxis (Bern 1994); 2005 Aug; 94(33):1243-54. PubMed ID: 16138769
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant therapies in extended pancreatectomy for ductal adenocarcinoma of the pancreas.
Ishikawa O; Ohigashi H; Sasaki Y; Masao K; Kabuto T; Furukawa H; Imaoka S
Hepatogastroenterology; 1998; 45(21):644-50. PubMed ID: 9684110
[TBL] [Abstract][Full Text] [Related]
32. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer.
Cohen SJ; Pinover WH; Watson JC; Meropol NJ
Curr Treat Options Oncol; 2000 Dec; 1(5):375-86. PubMed ID: 12057145
[TBL] [Abstract][Full Text] [Related]
34. [Trends for the management of pancreatic adenocarcinoma in a hospitalized-based population (1980-1994)].
Queneau PE; Pitard A; Labourey JM; Koch S; Sauve G; Carayon P
Gastroenterol Clin Biol; 2000 May; 24(5):501-5. PubMed ID: 10891737
[TBL] [Abstract][Full Text] [Related]
35. Modern management of pancreatic carcinoma.
Goldstein D; Carroll S; Apte M; Keogh G
Intern Med J; 2004 Aug; 34(8):475-81. PubMed ID: 15317546
[TBL] [Abstract][Full Text] [Related]
36. [Pancreatic adenocarcinoma: what treatment?].
Barbier L; Delpero JR
Rev Prat; 2014 Nov; 64(9):1297-8. PubMed ID: 25638875
[No Abstract] [Full Text] [Related]
37. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Papadoniou N; Kosmas C; Gennatas K; Polyzos A; Mouratidou D; Skopelitis E; Tzivras M; Sougioultzis S; Papastratis G; Karatzas G; Papalambros E; Tsavaris N
Anticancer Res; 2008; 28(1B):543-9. PubMed ID: 18383900
[TBL] [Abstract][Full Text] [Related]
39. [Best supportive care of pancreatic carcinoma].
Schoppmeyer K; Mössner J
Internist (Berl); 2004 Jul; 45(7):769-76. PubMed ID: 15160243
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Tempero MA; Malafa MP; Al-Hawary M; Asbun H; Bain A; Behrman SW; Benson AB; Binder E; Cardin DB; Cha C; Chiorean EG; Chung V; Czito B; Dillhoff M; Dotan E; Ferrone CR; Hardacre J; Hawkins WG; Herman J; Ko AH; Komanduri S; Koong A; LoConte N; Lowy AM; Moravek C; Nakakura EK; O'Reilly EM; Obando J; Reddy S; Scaife C; Thayer S; Weekes CD; Wolff RA; Wolpin BM; Burns J; Darlow S
J Natl Compr Canc Netw; 2017 Aug; 15(8):1028-1061. PubMed ID: 28784865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
